Merck & Co (MRK) Financials
Merck & Co (MRK) Historical Financial Statements and Key Metrics for 1994 - 2021
Full Merck & Co financials for 1994 - 2021 are available in the
US Historical Financials dataset
All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.
Merck & Co Income Statements
(in $ 000,000's)
| Quarter End | Revenue | Gross Profit | Operating Income | Net Income | EBITDA | EPS |
| 2021-Mar-31 | 12,080 | 8,410 (69.6 %) | 3,312 (27.4 %) | 3,179 (26.3 %) | 4,242 | 1.25 |
| 2020-Dec-31 | 12,515 | 6,982 (55.8 %) | -1,940 (-15.5 %) | -2,094 (-16.7 %) | -1,036 | -0.83 |
| 2020-Sep-30 | 12,551 | 9,070 (72.3 %) | 3,230 (25.7 %) | 2,941 (23.4 %) | 4,082 | 1.16 |
| 2020-Jun-30 | 10,872 | 7,713 (70.9 %) | 3,212 (29.5 %) | 3,002 (27.6 %) | 4,260 | 1.18 |
| 2020-Mar-31 | 12,057 | 8,745 (72.5 %) | 3,981 (33.0 %) | 3,219 (26.7 %) | 4,802 | 1.26 |
| 2019-Dec-31 | 11,868 | 8,199 (69.1 %) | 2,762 (23.3 %) | 2,356 (19.9 %) | 3,698 | 0.92 |
| 2019-Sep-30 | 12,397 | 8,407 (67.8 %) | 2,614 (21.1 %) | 1,901 (15.3 %) | 3,459 | 0.74 |
Full historical income statements for 1994 - 2021 is included in the
US Historical Financials dataset.
Merck & Co Balance Sheets
(in $ 000,000's)
| Quarter End | Total Assets | Total Liabilities | Total Debt | Total Equity | Cash & Equivalents |
| 2021-Mar-31 | 90,847 | 63,808 | 31,253 | 26,945 | 6,981 |
| 2020-Dec-31 | 91,588 | 66,184 | 31,791 | 25,317 | 8,847 |
| 2020-Sep-30 | 89,800 | 60,530 | 28,741 | 29,186 | 7,356 |
| 2020-Jun-30 | 90,615 | 62,871 | 30,874 | 27,642 | 11,103 |
| 2020-Mar-31 | 84,913 | 58,613 | 27,998 | 26,205 | 7,432 |
| 2019-Dec-31 | 84,397 | 58,396 | 26,346 | 25,907 | 10,450 |
| 2019-Sep-30 | 83,331 | 56,406 | 26,088 | 26,838 | 8,018 |
Full historical balance sheet data for 1994 - 2021 is included in the
US Historical Financials dataset.
Merck & Co Cash Flow Statements
(in $ 000,000's)
| Quarter End | Operating Cash Flow | Investing | Financing | Free Cash Flow |
| 2021-Mar-31 | 1,791 | -738 | -2,098 | 657 |
| 2020-Dec-31 | 4,006 | -4,778 | 1,372 | 2,492 |
| 2020-Sep-30 | 2,173 | -2,155 | -3,851 | 657 |
| 2020-Jun-30 | 3,367 | -882 | 1,137 | 2,699 |
| 2020-Mar-31 | 707 | -1,628 | -1,490 | -279 |
| 2019-Dec-31 | 4,794 | -763 | -2,011 | 3,657 |
| 2019-Sep-30 | 4,226 | 191 | -3,152 | 3,267 |
Full historical cash flow data for 1994 - 2021 is included in the
US Historical Financials dataset.
Merck & Co Key Valuation and Operating Metrics
| Quarter End | Market Capitalization ($ 000,000's) |
Enterprise Value ($ 000,000's) |
Price/Earnings ($ 000,000's) |
Price/Sales ($ 000,000's) |
Price/Book ($ 000,000's) |
| 2021-Mar-31 | 195,115 | 219,387 | 16.15 | 15.34 | 7.24 |
| 2020-Dec-31 | 206,934 | 230,663 | 16.53 | -24.71 | 8.17 |
| 2020-Sep-30 | 209,844 | 231,229 | 16.72 | 17.84 | 7.19 |
| 2020-Jun-30 | 195,581 | 215,352 | 17.99 | 16.29 | 7.08 |
| 2020-Mar-31 | 194,198 | 214,771 | 16.11 | 15.08 | 7.41 |
| 2019-Dec-31 | 230,923 | 247,593 | 19.46 | 24.50 | 8.91 |
| 2019-Sep-30 | 214,734 | 232,953 | 17.32 | 28.24 | 8.00 |
Full historical valuation and operating metrics for 1994 - 2021 are included in the
US Historical Financials dataset.